Cointime

ExpressCells

company

About

ExpressCells creates custom cell lines for biological research and drug discovery.

  • 1 - 10

Highlights

Total Funding Amount
$1.20M
Funding Rounds
1
Investors
2

Details

Last Funding Type
Series A
Last Funding Money Raised
$1.20M
Industries
Biotechnology,Medical,Product Research
Founded date
Jan 1, 2018
Number Of Employee
1 - 10
Operating Status
Active

ExpressCells is a biotechnology company that uses genetic engineering to create custom cell lines for biological research and drug discovery. The company's primary focus is on creating research tools that will speed drug discovery and provide better disease models for basic researchers.

ExpressCells was established by Oscar Perez-Leal and Matt Handel in 2018 and is headquartered in Philadelphia, Pennsylvania.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$1.20M
ExpressCells has raised a total of $1.20M in funding over 2 rounds. Their latest funding was raised on Jul 1, 2019 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 1, 2019 Series A $1.20M 2 Rowan University Venture Fund
Keiretsu Forum Mid Atlantic 		— Detail

Investors

Number of Lead Investors
Number of Investors
2
2
ExpressCells is funded by 2 investors. Rowan University Venture Fund and Keiretsu Forum Mid Atlantic are the most recent investors.
Investor Name Lead Investor Funding Round
Rowan University Venture Fund Yes Series A
Keiretsu Forum Mid Atlantic Yes Series A
Cointime
Содержание
компания